Publications Using SART CORS

Publications Using SART CORS as of 10/21/2025

  1. Stern JE, Cedars MI, Jain T, Klein NA, Beaird CM, Grainger DA, Gibbons WE. Assisted reproductive technology practice patterns and the impact of embryo transfer guidelines in the United States. Fertil Steril. 2007;88:275-82.          
  2. Gibbons W, Grainger D, Cedars M, Jain T, Klein N, Stern J. Continuous quality improvement and assisted reproductive technology multiple gestations: some progress, some answers, more questions. Fertil Steril. 2007;88:301-4.
  3. Seifer DB, Frazier LM, Grainger DA. Disparity in assisted reproductive technologies outcomes in black women compared with white women. Fertil Steril. 2008;90:1701-10.
  4. Stern JE, Goldman MB, Hatasaka H, MacKenzie TA, Racowsky C, Surrey ES. Optimizing the number of blastocyst stage embryos to transfer on day 5 or 6 in women 38 years of age and older: a Society for Assisted Reproductive Technology database study. Fertil Steril. 2009; 91:157–66.
  5. Luke B, Brown MB, Grainger DA, Stern JE, Klein N, Cedars MI. The effect of early fetal losses on singleton assisted conception pregnancy outcomes. Fertil Steril. 2009; 91:2578–85.
  6. Luke B, Brown MB, Grainger DA, Baker VL, Ginsburg E, Stern JE. The sex ratio of singleton offspring in assisted conception pregnancies. Fertil Steril. 2009;92:1579–85.
  7. Fujimoto VY, Luke B, Brown MB, Jain T, Armstrong A, Grainger DA, Hornstein M. Racial and ethnic disparities in Assisted Reproductive Technology (ART) outcomes in the United States. Fertil Steril. 2010; 93:382–90.
  8. Luke B, Brown MB, Grainger DA, Cedars M, Klein N, Stern JE. Practice patterns and outcomes with the use of single embryo transfer in the United States. Fertil Steril. 2010;93:490–8.
  9. Luke B, Brown MB, Stern JE, Missmer SA, Fujimoto VY, Leach R. Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates. Hum Reprod. 2011; 26:245–52.
  10. Seifer DB, Zackula R, Grainger D. Trends of racial disparities in assisted reproductive technologies outcomes in Black women compared with White women: SART 1999–2000 versus 2004–2006. Fertil Steril. 2010;93:626–35.
  11. Racowsky C, Vernon M, Meyer J, Ball GD, Behr B, Pomeroy KO, Wininger D, Gibbons W, Conaghan J, Stern JE. Standardization of grading embryo morphology. Fertil Steril. 2010;94:1152–3.
  12. Stern JE, Brown MB, Luke B, Wantman E, Lederman A, Missmer SA, Hornstein MD. Cumulative live birth rates from linked cycles of assisted reproductive technology: data from the Massachusetts SART CORS. Fertil Steril. 2010;94:1334–40.
  13. Luke B, Brown MB, Morbeck DE, Hudson SB, Coddington CC 3rd, Stern JE. Factors associated with ovarian hyperstimulation syndrome and its effect on assisted reproductive technology treatment and outcome. Fertil Steril. 2010;94:1399–404.
  14. Baker VL, Luke B, Brown MB, Alvero R, Frattarelli JL, Usadi R, Grainger DA, Armstrong AY. Multivariate analysis of factors affecting probability of pregnancy and live birth with in vitro fertilization: an analysis of the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System. Fertil Steril. 2010;94:1410–6.
  15. Racowsky C, Vernon M, Meyer J, Ball GD, Behr B, Pomeroy KO, Wininger D, Gibbons W, Conaghan J, Stern JE. Standardization of grading embryo morphology. J Assist Reprod Genet. 2010;27:437–9.
  16. Luke B, Brown MB, Stern JE, Grainger DA, Klein N, Cedars M. Effect of embryo transfer number on singleton and twin implantation pregnancy outcomes after assisted reproductive technology. J Reprod Med. 2010;55:387–94.
  17. Luke B, Brown MB, Stern JE, Missmer SA, Fujimoto VY, Leach R. Female obesity adversely affects assisted reproductive technology pregnancy and live birth rates. Hum Reprod. 2011;26:245–52.
  18. Stern JE, Brown MB, Luke B, Wantman E, Lederman A, Hornstein MD. Cycle 1 as predictor of assisted reproductive technology treatment outcome over multiple cycles: an analysis of linked cycles from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System. Fertil Steril. 2011;95:600–5.
  19. Gibbons WE, Cedars M, Ness R. Toward understanding obstetrical outcome in advanced assisted reproduction: varying sperm, oocyte, and uterine source and diagnosis. Fertil Steril. 2011;95:1645–9.e1.
  20. Luke B, Brown MB, Stern JE, Missmer SA, Fujimoto VY, Leach R. Racial and ethnic disparities in assisted reproductive technology pregnancy and live birth rates within body mass index categories. Fertil Steril. 2011;95:1661–6.
  21. Racowsky C, Stern JE, Gibbons WE, Behr B, Pomeroy KO, Biggers JD. National collection of embryo morphology data into Society for Assisted Reproductive Technology Clinic Outcomes Reporting System: associations among day 3 cell number, fragmentation and blastomere asymmetry, and live birth rate. Fertil Steril. 2011;95:1985–9.
  22. Vernon M, Stern JE, Ball GD, Wininger D, Mayer J, Racowsky C. Utility of the national embryo morphology data collection by SART: Correlation between day 3 morphology grade and live birth outcome. Fertil Steril. 2011;95:2761-3.
  23. Nangia AK, Luke B, Megid WA, Smith J, Mak W, Stern JE. National study of factors influencing assisted reproductive technology (ART) outcomes with male factor infertility. Fertil Steril. 2011;96:609-14.
  24. Luke B, Brown MB, Missmer SA, Bukulmez O, Leach R, Stern JE. The effect of increasing obesity on the response to and outcome of assisted reproductive technology: a national study. Fertil Steril. 2011;96:820-5.
  25. Ginsburg ES, Baker VL, Racowsky C, Wantman E, Goldfarb J, Stern JE. Use of preimplantation genetic diagnosis and preimplantation genetic screening in the United States: a Society for Assisted Reproductive Technology Writing Group paper. Fertil Steril. 2011;96:865-8.
  26. Kalra SK, Ratcliffe SJ, Coutifaris C, Molinaro T, Barnhart KT. Ovarian stimulation and low birthweight in newborns conceived through in vitro fertilization. Obstet Gynecol. 2011;118:863-71.
  27. Calhoun KC, Fritz MA, Steiner AZ. Examining the relationship between ovarian reserve, as measured by basal FSH levels, and the risk of poor obstetric outcome in singleton IVF gestations. Hum Reprod. 2011;26:3424-30.
  28. Dickey RP, Xiong X, Gee RE, Pridjian G. Effect of maternal height and weight on risk of preterm birth in singleton and twin births resulting from in vitro fertilization: a retrospective cohort study using the Society for Assisted Reproductive Technology Clinic Outcome Reporting System. Fertil Steril. 2012;97:349-54.
  29. Stern JE, Hickman TN, Kinzer D, Penzias AS, Ball GD, Gibbons WE. Can the Society for Assisted Reproductive Technology Clinic Outcome Reporting System (SART CORS) be used to accurately report clinic total reproductive potential (TRP)? Fertil Steril. 2012;97:886-9.
  30. Stern JE, Lieberman ES, Macaluso M, Racowsky C. Is cryopreservation of embryos a legitimate surrogate marker of embryo quality in studies of assisted reproductive technology conducted using national databases? Fertil Steril. 2012;97:890-3.
  31. Luke B, Brown MB, Wantman E, Lederman A, Gibbons W, Schattman GL, Lobo RA, Leach RE, Stern JE. Cumulative birth rates with linked assisted reproductive technology cycles. N Engl J Med. 2012;366:2483-91.
  32. Kalra SK, Ratcliffe SJ, Barnhart KT, Coutifaris C. Extended embryo culture and an increased risk of preterm delivery. Obstet Gynecol. 2012;120:69-75.
  33. Wellons MF, Fujimoto VY, Baker VL, Barrington DS, Broomfield D, Catherino WH, Richard-Davis G, Ryan M, Thornton K, Armstrong AY. Race matters: a systematic review of racial/ethnic disparity in Society for Assisted Reproductive Technology reported outcomes. Fertil Steril. 2012;98:406-9.
  34. Sunderam S, Kissin DM, Flowers L, Anderson JE, Folger SG, Jamieson DJ, Barfield WD; Centers for Disease Control and Prevention (CDC). Assisted reproductive technology surveillance–United States, 2009. MMWR Surveill Summ. 2012 Nov 2;61(7):1-23.
  35. Stern JE, Brown MB, Wantman E, Kalra SK, Luke B. Live birth rates and birth outcomes by diagnosis using linked cycles from the SART CORS database. J Assist Reprod Genet. 2013;30:1445-50.
  36. Dickey RP, Xiong X, Xie Y, Gee RE, Pridjian G. Effect of maternal height and weight on risk for preterm singleton and twin births resulting from IVF in the United States, 2008-2010. Am J Obstet Gynecol. 2013;209:349.e1-6.
  37. Xiong X, Pridjian G, Dickey RP. Racial and ethnic disparities in preterm births in infants conceived by in vitro fertilization in the United States. Am J Obstet Gynecol. 2013;209:128.e1-6.
  38. Butts SF, Ratcliffe S, Dokras A, Seifer DB. Diagnosis and treatment of diminished ovarian reserve in assisted reproductive technology cycles of women up to age 40 years: the role of insurance mandates. Fertil Steril. 2013;99:382-8.
  39. Gordon JD, Dimattina M, Reh A, Botes A, Celia G, Payson M. Utilization and success rates of unstimulated in vitro fertilization in the United States: an analysis of the Society for Assisted Reproductive Technology database. Fertil Steril. 2013;100:392-5.
  40. Luke B, Brown MB, Wantman E, Baker VL, Grow DR, Stern JE. Second try: who returns for additional ART treatment and the effect of a prior ART birth. Fertil Steril. 2013;100:1580-4.
  41. Declercq ER, Belanoff C, Diop H, Gopal D, Hornstein MD, Kotelchuck M, Luke B, Stern JE. Identifying women with indicators of subfertility in a statewide population database: Operationalizing the missing link in ART research. Fertil Steril. 2014;101:463-71.
  42. Marshall SM, Onwubalili N, Brown K, Jindal SK, McGovern PG. Blastocyst expansion score and trophectoderm morphology strongly predict successful clinical pregnancy and live birth following elective single embryo blastocyst transfer (SET): A national study. J Assist Reprod Genet. 2013;30:1577-81.
  43. Luke B, Brown MB, Wantman E, Stern JE. Factors associated with monozygosity in assisted reproductive technology pregnancies and the risk of recurrence using linked cycles. Fertil Steril. 2014;101:683-9.
  44. Steward RG, Lan L, Shah AA, Yeh JS, Price TM, Goldfarb JM, Muasher SJ. Oocyte number as a predictor for ovarian hyperstimulation syndrome and live birth: an analysis of 256,381 in vitro fertilization cycles. Fertil Steril. 2014;101:967-73.
  45. Kotelchuck M, Hoang L, Stern JE, Diop H, Belanoff C, Declercq E. The MOSART Database: Linking the SART CORS Clinical Database to the Population-Based Massachusetts PELL Reproductive Public Health Data System. Matern Child Health J. 2014;18:2167-78.
  46. Stern JE, Kotelchuck M, Luke B, Declercq E, Cabral H, Diop H. Calculating length of gestation from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System (SART CORS) database versus vital records may alter reported rates of prematurity. Fertil Steril. 2014;101:1315-20.
  47. Liberman RF, Stern JE, Luke B, Reefhuis J, Anderka M. Maternal Self-Report of Assisted Reproductive Technology Use in the National Birth Defects Prevention Study: Validation using fertility clinic data. Epidemiology. 2014;25:773-5.
  48. Yeh JS, Steward RG, Dude AM, Shah AA, Goldfarb JM, Muasher SJ. Pregnancy outcomes decline in recipients over age 44: an analysis of 27,959 fresh donor oocyte in vitro fertilization cycles from the Society for Assisted Reproductive Technology. Fertil Steril. 2014;101:1331-6.
  49. Luke B, Brown MB, Stern JE, Jindal SK, Racowsky C, Ball GD. Using the Society for Assisted Reproductive Technology Clinic Outcome System morphological measures to predict live birth after assisted reproductive technology. Fertil Steril. 2014;102:1338-44.
  50. Gee RE, Dickey RP, Xiong X, Clark LS, Pridjian G. Impact of monozygotic twinning on multiple births resulting from in vitro fertilization in the United States, 2006-2010. Am J Obstet Gynecol. 2014;210:468.e1-6.
  51. Stern JE, Luke B, Hornstein MD, Cabral H, Gopal D, Diop H, Kotelchuck M. The effect of father’s age in fertile, subfertile, and assisted reproductive technology pregnancies: A population-based cohort study. J Assist Reprod Genet. 2014;31:1437-44.
  52. Yeh JS, Steward RG, Dude AM, Shah AA, Goldfarb JM, Muasher SJ. Pregnancy rates in donor oocyte cycles compared to similar autologous in vitro fertilization cycles: an analysis of 26,457 fresh cycles from the Society for Assisted Reproductive Technology. Fertil Steril. 2014;102:399-404.
  53. Luke B, Brown MB, Wantman E, Stern JE, Baker VL, Widra E, Coddington CC 3rd, Gibbons WE, Ball GD. A prediction model for live birth and multiple births within the first three cycles of assisted reproductive technology. Fertil Steril. 2014;102:744-52.
  54. Butts SF, Owen C, Mainigi M, Senapati S, Seifer DB, Dokras A. Assisted hatching and intracytoplasmic sperm injection are not associated with improved outcomes in assisted reproduction cycles for diminished ovarian reserve: an analysis of cycles in the United States from 2004 to 2011. Fertil Steril. 2014;102:1041-7.
  55. Liberman RF, Stern JE, Luke B, Reefhuis J, Anderka M. Validating assisted reproductive technology self-report. Epidemiology. 2014;25:773-5.
  56. Pal L, Kidwai N, Kayani J, Grant WB. Donor egg IVF model to assess ecological implications for ART success. J Assist Reprod Genet. 2014;31:1453-60.
  57. Xiong X, Dickey RP, Pridjian G, Buekens P. Maternal age and preterm births in singleton and twin pregnancies conceived by in vitro fertilization in the United States. Paediatr Perinat Epidemiol. 2015;29:22-30.
  58. Fechner AJ, Brown KR, Onwubalili N, Jindal SK, Weiss G, Goldsmith LT, McGovern PG. Effect of single embryo transfer on the risk of preterm birth associated with in vitro fertilization. J Assist Reprod Genet. 2015;32:221-4.
  59. Baker VL, Brown MB, Luke B, Conrad KP. Association of number of retrieved oocytes with live birth rate and birth weight: an analysis of 231,815 cycles of in vitro fertilization. Fertil Steril. 2015;103:931-8.
  60. Luke B, Brown MB, Wantman E, Stern JE, Baker VL, Widra E, Coddington CC 3rd, Gibbons WE, Van Voorhis BJ, Ball GD. Application of a validated prediction model for in vitro fertilization: Comparison of live birth rates and multiple birth rates with one embryo transferred over two cycles versus two embryos in one cycle. Am J Obstet Gynecol. 2015;212:676.e1-7.
  61. Declercq E, Luke B, Belanoff C, Cabral H, Diop H, Gopal D, Hoang L, Kotelchuck M, Stern JE, Hornstein MD. Perinatal outcomes associated with assisted reproductive technology: The Massachusetts outcomes study of assisted reproductive technologies (MOSART). Fertil Steril. 2015;103:888-95.
  62. Baker VL, Brown MB, Luke B, Smith GW, Ireland JJ. Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles. Fertil Steril. 2015;104:1145-52.e1-5.
  63. Stern JE, Luke B, Tobias M, Gopal D, Hornstein MD, Diop H. Adverse pregnancy and birth outcomes by infertility diagnoses with and without ART treatment. Fertil Steril. 2015;103:1438-45.
  64. Buck Louis GM, Druschel C, Bell E, Stern JE, Luke B, McLain A, Sundaram R, Yeung E. Use of assisted reproductive technology treatment as reported by mothers in comparison with registry  the Upstate KIDS Study. Fertil Steril. 2015;103:1461-8.
  65. Luke B, Stern JE, Kotelchuck M, Declercq ER, Hornstein MD, Gopal D, Hoang L, Diop H. Adverse pregnancy outcomes after in vitro fertilization: Effect of number of embryos transferred and plurality at conception. Fertil Steril. 2015;104:79-86.
  66. Declercq ER, Luke B, Stern JE, Diop H, Gopal D, Cabral H, Belanoff C, Kotelchuck M. Maternal postpartum hospitalization following ART births (Research letter). Epidemiology. 2015;26:e64-65.
  67. Luke B, Brown MB, Spector LG, Missmer SA, Leach RE, Williams M, Koch L, Smith Y, Stern JE, Ball GD, Schymura MJ. Cancer in women after assisted reproductive technology. Fertil Steril. 2015;104:1218-26.
  68. Luke B, Stern JE, Kotelchuck M, Declercq E, Cohen B, Diop H. Birth outcomes by infertility diagnosis: Analyses of the Massachusetts Outcomes Study of Assisted Reproductive Technologies (MOSART). J Reprod Med. 2015;60:480-90.
  69. Acharya KS, Acharya CR, Provost MP, Yeh JS, Steward RG, Eaton JL, Muasher SJ. Ectopic pregnancy rate increases with the number of retrieved oocytes in autologous in vitro fertilization with non-tubal infertility but not donor/recipient cycles: an analysis of 109,140 clinical pregnancies from the Society for Assisted Reproductive Technology registry. Fertil Steril. 2015 Oct;104(4):873-8.
  70. Luke B, Brown MB, Missmer SA, Spector LG, Leach RE, Williams M, Koch L, Smith YR, Stern JE, Ball GD, Schymura MJ. Assisted reproductive technology use and outcomes among women with a history of cancer. Hum Reprod. 2016;31:183-9.
  71. Luke B, Stern JE, Hornstein MD, Kotelchuck M, Diop H, Cabral H, Declercq ER. Is the wrong question being asked in infertility research? J Assist Reprod Genet. 2016;33:3-8.
  72. Diop H, Gopal D, Cabral H, Belanoff C, Declercq ER, Kotelchuck M, Luke B, Stern JE. Assisted reproductive technology and Early Intervention enrollment. Pediatrics. 2016;137(3):e20152007.
  73. Belanoff C, Declercq ER, Diop H, Gopal D, Kotelchuck M, Luke B, Nguyen T, Stern JE. Severe maternal morbidity and the use of assisted reproductive technology. Obstet Gynecol. 2016;127:527-34.
  74. Luke B, Stern JE, Kotelchuck M, Declercq E, Anderka M, Diop H. Birth outcomes by infertility treatment: Analyses of the Massachusetts Outcomes Study of Assisted Reproductive Technologies (MOSART). J Reprod Med. 2016;61:114-27.
  75. Luke B, Brown MB, Spector LG, Stern JE, Smith YR, Williams M, Koch L, Schymura MJ. Embryo banking among women diagnosed with cancer: A population-based study in New York, Texas, and Illinois. J Assist Reprod Genet. 2016;33:667-74.
  76. Toner J, Coddington CC, Doody K, van Voorhis B, Seifer D, Ball GD, Luke B, Wantman E. SART & ART in the US: a 2016 Update. Fertil Steril. 2016;106:541-6.
  77. Dickey RP, Xiong X, Pridjian G, Klempel MC. Singleton birthweight by gestational age following in vitro fertilization in the United States. Am J Obstet Gynecol. 2016;214(1):101.e1-13.
  78. Seifer DB, Tal O, Wantman E, Edul P, Baker VL. Prognostic indicators of ART outcomes of cycles with ultra-low serum anti-müllerian hormone (AMH): a multivariate analysis of over 5000 autologous cycles from the SART CORS database for 2012-2013. Fertil Steril. 2016;105:385-93.
  79. Styer AK, Luke B, Christianson MS, Vitek W, Baker V, Armstrong A, Polotsky AJ. Factors associated with the use of elective single embryo transfer and pregnancy outcomes in the United States 2004-2012. Fertil Steril. 2016;106:80-9.
  80. Luke B, Brown MB, Spector LG. Validation of Infertility Treatment and Assisted Reproductive Technology Use On the Birth Certificate in Eight States. Am J Obstet Gynecol. 2016;215:126-7.
  81. Stern JE, McLain AC, Buck Louis GM, Luke B, Yeung EH. Accuracy of self-reported survey data on assisted reproductive technology treatment parameters and reproductive history. Am J Obstet Gynecol. 2016;215:219.e1-6.
  82. Acharya KS, Keyhan S, Acharya CR, Yeh JS, Provost MP, Goldfarb JM, Muasher SJ. Do donor oocytes cycles comply with ARM/SART embryo transfer guidelines? An analysis of 13,393 donor cycles from the SART registry. Fertil Steril. 2016;106:603-7.
  83. Keyhan S, Acharya KS, Acharya CR, Yeh SJ, Provost MP, Goldfarb JM, Muasher SJ. How compliant are in vitro fertilization member clinics in following embryo transfer guidelines? An analysis of 59,689 fresh first in vitro fertilization autologous cycles from 2011 to 2012. Fertil Steril. 2016;106:645-52.
  84. Dude AM, Yeh JS, Muasher SJ. Donor oocytes are associated with preterm birth when compared to fresh autologous in vitro fertilization cycles in singleton pregnancies. Fertil Steril. 2016;106:660-5.
  85. Stern JE, Gopal D, Liberman R, Anderka M, Kotelchuck M, Luke B. Validation of birth outcomes from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System (SART CORS): population-based analysis from Massachusetts Outcome Study of Assisted Reproductive Technology (MOSART). Fertil Steril. 2016;106:717-22.
  86. Luke B, Gopal D, Cabral H, Diop H, Stern JE. Perinatal outcomes of singleton siblings: The effects of maternal fertility status and ART treatment. J Assist Reprod Genet. 2016;33:1203-13.
  87. Grimstad FW, Nangia AK, Luke B, Stern JE, Mak W. Use of ICSI in IVF cycles in women with tubal ligation does not improve pregnancy or live birth rates. Hum Reprod. 2016;31:2750-5.
  88. Provost MP, Thomas SM, Yeh JS, Hurd WH, Eaton JL. State insurance mandates and multiple birth rates after in vitro fertilization. Obstet Gynecol. 2016;128:1205-14.
  89. Provost MP, Acharya KS, Acharya CR, Yeh JS, Steward RG, Eaton JL, Goldfarb JM, Muasher SJ. Pregnancy outcomes decline with increasing body mass index: analysis of 239,127 fresh autologous in vitro fertilization cycles from the 2008-2010 Society for Assisted Reproductive Technology registry. Fertil Steril. 2016;105(3):663-9.
  90. Provost MP, Acharya KS, Acharya CR, Yeh JS, Steward RG, Eaton JL, Goldfarb JM, Muasher SJ. Pregnancy outcomes decline with increasing recipient body mass index: an analysis of 22,317 fresh donor/recipient cycles from the 2008-2010 Society for Assisted Reproductive Technology Clinic Outcome Reporting System registry. Fertil Steril. 2016;105(2):364-8.
  91. Yeung EH, Sundaram R, Bell EM, Druschel C, Kus C, Xie Y, Buck Louis GM. Infertility treatment and children’s longitudinal growth between birth and 3 years of age. Hum Reprod. 2016 Jul;31(7):1621-8.
  92. Dickey RP, Pridjian G, Xiong X, Klempel MC. Birth weight by gestational age for 76,710 twins born in the United States as a result of In Vitro Fertilization: 2006-2010. Am J Perinatol. 2017;34:31-7.
  93. Kushnir VA, Darmon SA, Shapiro AJ, Albertini DF, Barad DH, Gleicher N. Utilization of third party reproductive technology in the United States. Am J Obstet Gynecol. 2017 Mar;216(3):266.e1-10.
  94. Wang ET, Kathiresan ASQ, Bresee C, Greene N, Alexander C, Pisarska MD. Abnormal implantation after fresh and frozen in vitro fertilization cycles. Fertil Steril. 2017;107:1153-8.Shapiro AJ, Darmon SK, Barad DH,
  95. Albertini DF, Gleicher N, Kushnir VA. Effect of race and ethnicity on utilization and outcomes of assisted reproductive technology in the USA. Reprod Biol Endocrinol. 2017;15:44.
  96. Xiong X, Dickey RP, Buekens P, Shaffer J, Pridjian G. Use of Intracytoplasmic Sperm Injection and Birth Outcomes in Women Conceiving Through In Vitro Fertilization. Paediatr Perinat Epidemiol. 2017;31(2):108-115.
  97. Knudtson JF, Failor CM, Gelfond JA, Goros MW, Chang TA, Schenken RS, Robinson RD. Assisted hatching and live births in first-cycle frozen embryo transfers. Fertil Steril. 2017;108:628-33.
  98. Luke B, Brown MB, Wantman E, Stern JE, Toner J, Coddington CC. Increased risk of large-for-gestational age birthweight in singleton siblings conceived with in vitro fertilization in frozen versus fresh cycles. J Assist Reprod Genet. 2017;34:191-200.
  99. Luke B, Gopal D, Stern JE, Diop H. Pregnancy, birth, and infant outcomes by maternal fertility status: The Massachusetts Outcomes Study of Assisted Reproductive Technology. Am J Obstet Gynecol. 2017;217:327.e1-14.
  100. Luke B, Gopal D, Stern JE, Diop H. Adverse pregnancy, birth, and infant outcomes in twins: Effects of maternal fertility status and infant gender combination. The Massachusetts Outcomes Study of Assisted Reproductive Technology. Am J Obstet Gynecol. 2017;217:330.e1-15
  101. Luke B. Invited Expert Review. Adverse effects of female obesity and interaction with race on reproductive potential. Fertil Steril. 2017;107:868-77.
  102. Stern JE, Gopal D, Diop H, Missmer S, Coddington C, Luke B. Inpatient hospitalizations in women with and without assisted reproductive technology live birth. J Assist Reprod Genet. 2017;34:1043-9.
  103. Liberman R, Getz KD, Luke B, Stern JE, Declercq ER, Chen X, Anderka M. Assisted reproductive technology and birth defects: Effects of subfertility and multiple births. Birth Defects Res. 2017;109:1144-53.
  104. Barad DH, Darmon SK, Kushnir VA, Albertini DF, Gleicher N. Impact of preimplantation genetic screening on donor oocyte-recipient cycles in the United States. Am J Obstet Gynecol. 2017;217:576.e1-e8.
  105. Mersereau J, Stanhiser J, Coddington C, Jones T, Luke B, Brown MB. Patient and cycle characteristics predicting high pregnancy rates with single embryo transfer: an analysis of the SART outcomes between 2004 and 2013. Fertil Steril. 2017;108:750-6.
  106. Luke B. Invited Expert Review. Pregnancy and birth outcomes in couples with infertility with and without assisted reproductive technology: With an emphasis on US population-based studies. Am J Obstet Gynecol. 2017;217:270-81.
  107. Luke B, Brown MB, Liu CL, Diop H, Stern JE. Validation of severe maternal morbidity on the US certificate of live birth. Epidemiology. 2018;29:e31-e32.
  108. Vega M, Zaghi S, Buyuk E, Jindal S. Not all twins are monozygotic after elective single embryo transfer: analysis of 32,600 elective single embryo transfer cycles as reported to the Society for Assisted Reproductive Technology. Fertil Steril. 2018;109:118-22.
  109. Tal R, Seifer DB, Wantman E, Baker V, Tal O. Antimullerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society of Assisted Reproductive Technology Clinic Outcome Reporting System database for 2012-2013. Fertil Steril. 2018;109:258-65.
  110. Murugappan G, Farland LV, Missmer SA, Correia KF, Anchan RM, Ginsburg ES. Gestational carrier in assisted reproductive technology. Fertil Steril. 2018;109:420-8.
  111. Holden EC, Kashani BN, Morelli SS, Alderson D, Jindal SK, McGovern PG. Improved outcomes after blastocyst stage frozen, thawed embryo transfers compared to cleavage stage: a SART CORS study. Fertil Steril. 2018;110:89-94.
  112. Keyhan S, Truong T, Li Y-J, Jackson-Bey T, Eaton J. Preterm delivery and low birth weights among neonates conceived with intracytoplasmic sperm injection compared with conventional in vitro fertilization. Obstet Gynecol. 2018;131:262-8.
  113. Quinn MM, Rosen MP, Huddleston HG, Cedars MI, Fujimoto VI. Interpregnancy interval (IPI) and singleton live birth outcomes from in vitro fertilization (IVF). Obstet Gynecol. 2018;132:115-21.
  114. Quinn MM, Rosen MP, Allen IE, Huddleston HG, Cedars MI, Fujimoto VY. Decreased clinical pregnancy and live birth rates from delivery to subsequent assisted reproductive treatment cycle. Hum Reprod. 2018;33:1316-21.
  115. Amrane S, Lobo R, Brown MB, Luke B. Factors associated with interpregnancy interval among women treated with in vitro fertilization. J Assist Reprod Genet. 2018;35:1595-602.
  116. Nichols HB, Anderson C, Ruddy K, Black KZ, Luke B, Engel S, Mersereau J. Childbirth after adolescent and young adult cancer in North Carolina, 2000-2014. J Cancer Surviv. 2018;12:592-600.
  117. Mahesan AM, Sadek S, Moussavi V, Vazifedan T, Majeed A, Cunningham T, Oehninger S, Bocca S. Clinical outcomes following ICSI cycles using surgically recovered sperm and the impact of maternal age: 2004-2015 SART CORS registry. J Assist Reprod Genet. 2018;35:1239-46.
  118. Vega M, Zaghi S, Buyuk E, Jindal S, Yu B. Comparison of perinatal outcomes following frozen embryo transfer cycles using autologous versus donor oocytes in women 40 to 43 years old: analysis of SART CORS data. J Assist Reprod Genet. 2018;35:2025-9.
  119. Acharya KS, Acharya CR, Bishop K, Harris B, Raburn D, Muasher SJ. Freezing of all embryos in in vitro fertilization is beneficial in high responders, but not intermediate and low responders: an analysis of 82,935 cycles from the Society for Assisted Reproductive Technology registry. Fertil Steril. 2018;110:880-7.
  120. Luke B, Boulet S, Henningsen AKA. Chapter 3.5. Monitoring long-term outcomes of ART practice: Linking ART surveillance data with other datasets. In: Kissin D, Adamson D, Chambers G, editors. Assisted Reproductive Technology Surveillance. Oxford: Cambridge University Press.
  121. Seifer DB, Wantman E, Sparks AT, Luke B, Doody KJ, Toner JP, Van Voorhis BJ, Reindollar RH. National survey of the Society for Assisted Reproductive Technology membership regarding insurance coverage for assisted reproductive technologies. Fertil Steril. 2018;110:1081-8.
  122. Yu B, Fritz R, Negassa A, Xie X, Jindal S, Vega M, Buyuk E. The impact of using donor sperm in assisted reproductive technology cycles on perinatal outcomes. Fertil Steril. 2018;110:1285-9.
  123. Segal TR, Kim K, Mumford SL, Goldfarb JM, Weinerman RS. How much does the uterus matter? Perinatal outcomes are improved when donor oocyte embryos are transferred to gestational carriers compared to intended parent recipients. Fertil Steril. 2018;110:888-95.
  124. Nichols HB, Anderson C, Ruddy K, Black KZ, Luke B, Engel S, Mersereau J. Childbirth after adolescent and young adult cancer: a population-based study. J Cancer Surviv. 2018;12:592-600.
  125. Stern JE, Liu CL, Cabral HJ, Richards EG, Coddington CC, Dukhovny D, Diop H, Missmer SA. Birth outcomes of singleton vaginal deliveries to ART-treated, subfertile, and fertile primiparous women. J Assist Reprod Genet. 2018;35(9):1585-93.
  126. Dukhovny D, Hwang SS, Gopal D, Cabral H, Missmer SA, Diop H, Declercq E, Stern JE. Length of stay and cost of birth hospitalization: effects of subfertility and ART. J Perinatol. 2018 Aug. doi:10.1038/s41372-018-0205-9.
  127. Hwang SS, Dukhovny D, Gopal D, Cabral H, Missmer SA, Diop H, Declercq E, Stern JE. Health of infants following ART-treated, subfertile, and fertile deliveries in Massachusetts. Pediatrics. 2018;142(2):e20174069.
  128. Stern JE, Liu CL, Cabral H, Richards EG, Coddington CC, Missmer SA, Diop H. Factors associated with the increased odds of cesarean delivery in ART pregnancies. Fertil Steril. 2018;110(3):429-36.
  129. Vitek W, Sun F, Baker VL, Styer AK, Christianson MS, Stern JE, Zhang H, Polotsky A. Lower Anti-Mullerian Hormone is associated with lower oocyte yield but not live birth rate among women with obesity. Am J Obstet Gynecol. 2019 Oct;222(4):363.
  130. Luke B, Brown MB, Wantman E, Baker VL, Doody K, Seifer DB, Spector LG. Risk of severe maternal morbidity by maternal fertility status: a US study in 8 states. Am J Obstet Gynecol. 2019;220:195.e1-195.e12.
  131. Hipp HS, Shandley L, Schirmer DA, McKenzie L, Kawwass JF. Oocyte cryopreservation in adolescent women. J Pediatr Adolesc Gynecol. 2019;32(4):377-82.
  132. Luke B, Brown MB, Wantman E, Seifer DB, Sparks AT, Lin PC, Doody KJ, Van Voorhis BJ, Spector LG. Risk of prematurity and infant morbidity and mortality by maternal fertility status and plurality. J Assist Reprod Genet. 2019;36:121-38.
  133. Spector LG, Brown MB, Wantman E, Letterie GS, Toner JP, Doody K, Ginsburg E, Williams M, Koch L, Schymura MJ, Luke B. Association of in vitro fertilization with childhood cancer in the United States. JAMA Pediatr. 2019;173:e190392.
  134. Jain T, Grainger DA, Ball GD, Gibbons WE, Rebar RW, Robins JC, Leach RE. 30 years of  impact of the United States in vitro fertilization data registry on advancing fertility care. Fertil Steril. 2019;111:477-88.
  135. Ligon S, Lustik M, Levy G, Pier B. Low antimullerian hormone (AMH) is associated with decreased live birth after in vitro fertilization when follicle stimulating-hormone and AMH are discordant. Fertil Steril. 2019;112:73-81.
  136. Quinn MM, Rosen MP, Allen IE, Huddleston HG, Cedars MI, Fujimoto VI. Interpregnancy interval (IPI) and singleton live birth outcomes after frozen embryo transfer. Fertil Steril. 2019;111:1145-50.
  137. Smeltzer S, Acharya K, Truong T, Pieper C, Muasher S. Clinical pregnancy (CP) and live birth (LB) increase significantly with each additional fertilized oocyte up to nine, and CP and LB decline after that: an analysis of 15,803 first fresh in vitro fertilization cycles from the Society for Assisted Reproductive Technology registry. Fertil Steril. 2019;112:520-6.
  138. Diop H, Cabral H, Gopal D, Cui X, Stern JE, Kotelchuck M. Early autism spectrum disorders in children born to fertile, subfertile, and ART-treated women. Matern Child Health J. 2019;23:1489-99.
  139. McLaughlin JE, Choi BY, Liu Q, Gelfond JA, Robinson RD, Chang A, Knudtson J. Does assisted hatching affect live birth in fresh, first in vitro fertilization in good and poor prognosis patients? J Assist Reprod Genet. 2019;36(12):2425-33.
  140. Stern JE, Liu CL, Cabral H, Gopal D, Harvey E, Missmer SA, Diop H, Coddington CC. Hospitalization before and after delivery in fertile, subfertile, and ART-treated women. J Assist Reprod Genet. 2019;36:1989-97.
  141. Hwang S, Dukhovny D, Gopal D, Cabral H, Diop H, Coddington CC, Stern JE. Infant health and fresh versus frozen embryo transfer. Fertil Steril. 2019;112(5):900-7.
  142. Stern JE, Liu CL, Hwang SS, Dukhovny D, Diop H, Cabral H. Contributions to prematurity of maternal health conditions, subfertility, and assisted reproductive technology. Fertil Steril. 2020;114(4):828-36.
  143. Shaia K, Truong T, Pieper C, Steiner A. Pre-implantation genetic testing alters the sex ratio: an analysis of 91,805 embryo transfer cycles. J Assist Reprod Genet. 2020;37:1117-22.
  144. Christianson MS, Stern JE, Sun F, Zhang H, Styer AK, Vitek W, Polotsky AJ. Embryo cryopreservation and utilization in the United States from 2004-2013. FS Rep. 2020;1(2):71-7.
  145. Ibrahim Y, Stoddard G, Johnstone E. A clinical counseling tool predicting supernumerary embryos after a fresh IVF cycle. J Assist Reprod Genet. 2020;37:1137-45.
  146. McGowan R, Pilipenko V, Smolarek TA, West E, Tolusso LK. Aneuploid embryo transfer: clinical policies and provider opinions at United States fertility clinics. Fertil Steril. 2020;114:110-7.
  147. Kawwass JF, Shandley LM, Boulet SL, Hipp HS. Oncologic oocyte cryopreservation: national comparison of fertility preservation between women with and without cancer. J Assist Reprod Genet. 2020;37:883-90.
  148. Roeca C, Johnson R, Carlson N, Polotsky AJ. Preimplantation genetic testing (PGT) and chances of a healthy livebirth amongst recipients of fresh donor oocytes in the United States. J Assist Reprod Genet. 2020;37:2283-92.
  149. Shaia KL, Acharya KS, Harris BS, Weber JM, Truong T, Muasher SJ. Total follicle stimulating hormone dose is negatively correlated with live births in a donor/recipient model with fresh transfer: an analysis of 8,627 cycles from the Society for Assisted Reproductive Technology Registry. Fertil Steril. 2020;114:545-51.
  150. Eaton JL, Truong T, Li YJ, Polotsky AJ. Prevalence of a good perinatal outcome with cryopreserved compared with fresh donor oocytes. Obstet Gynecol. 2020;135:709-16.
  151. McLaughlin JE, Choi BY, Liu Q, Gelfond JA, Robinson RD, Chang A, Knudtson J. Does assisted hatching affect live birth in fresh, first in vitro fertilization in good and poor prognosis patients? J Assist Reprod Genet. 2019;36(12):2425-33.
  152. Seifer DB, Simsek B, Wantman E, Kotlyar AM. Status of racial disparities between black and white women undergoing assisted reproductive technology in the United States. Reprod Biol Endocrinol. 2020;18(1):113.
  153. Luke B, Brown MB, Nichols HB, Schymura MJ, Browne ML, Fisher SC, Foriestieri NE, Rao C, Yazdy MM, Gershman ST, Ethen MK, Canfield MA, Williams M, Wantman E, Oehninger S, Doody KJ, Eisenberg ML, Baker VL, Lupo PJ. Assessment of birth defects and cancer risk in children conceived via in vitro fertilization in the US. JAMA Netw Open. 2020;3(10):e2022927.
  154. Luke B, Brown MB, Eisenberg ML, Callan C, Botting BJ, Pacey A, Sutcliffe AG, Baker VL. In vitro fertilization and risk for hypertensive disorders of pregnancy: associations with treatment parameters. Am J Obstet Gynecol. 2020;222(4):350.e1-350.e13.
  155. Cohen A, Kappy M, Fazzari M, Gerber RS, Galperin S, Lieman H, Jindal S, Buyuk E. Length of ovarian stimulation does not impact live birth in fresh donor oocyte cycles: a SART CORS study. J Assist Reprod Genet. 2020;37(12):3033-8.
  156. Luke B, Brown MB, Ethen MK, Canfield MA, Watkins S, Wantman E, Doody KJ. Third grade achievement among children conceived with the use of in vitro fertilization: a population-based study in Texas. Fertil Steril. 2020;113(6):1242-50.
  157. Roeca C, Johnson R, Truong T, Carlson N, Polotsky AJ. Transfer of fresh versus frozen embryos for donor oocyte recipients. Hum Reprod. 2020;35(12):2850-9.
  158. Gerber RS, Fazzari M, Kappy M, Cohen A, Galperin S, Lieman H, Jindal S, Buyuk B. Differential impact of controlled ovarian hyperstimulation on live birth rate in fresh vs frozen embryo transfer cycles: a SART CORS study. Fertil Steril. 2020;114(6):1225-31.
  159. Coddington CC, Gopal D, Ciu X, Cabral H, Diop H, Stern JE. Influence of subfertility and ART treatment on mortality of women after delivery. Fertil Steril. 2020;113(3):569-77.
  160. Luke B, Brown MB, Wantman E, Forestieri NE, Browne ML, Fisher SC, Yazdy MM, Ethen MK, Canfield MA, Watkins S, Nichols HB, Farland LV, Oehninger S, Doody KJ, Eisenberg ML, Baker VL. The risk of birth defects with conception by ART. Hum Reprod. 2021;36(1):116-29.
  161. Meng F, Goldsammler M, Wantman E, Buyuk E, Jindal SK. Live birth rate from euploid blastocysts is not associated with infertility etiology or oocyte source following frozen-thawed embryo transfer (FET): analysis of 4,148 cycles reported to SART CORS. J Assist Reprod Genet. 2021;38(1):185-92.
  162. Ibrahim Y, Stoddard GJ, Johnstone E. A validated prediction score for having two or more embryos for cryopreservation following freeze-all IVF cycles: an analysis utilizing SART CORS database. J Assist Reprod Genet. 2021;38(2):397-405.
  163. Johnston M, Richings NM, Leung A, Sakkas D, Catt C. A major increase in oocyte cryopreservation cycles in the USA, Australia and New Zealand since 2010 is highlighted by younger women but a need for standardized data collection. Hum Reprod. 2021;36(3):624-35.
  164. Clark Z, Thakur M, Leach RE, Ireland JJ. FSH dose is negatively correlated with number of oocytes retrieved: analysis of ~650,000 assisted reproductive technology cycles. J Assist Reprod Genet. 2021;doi:10.1007/s10815-021-02179-0.
  165. Sites CK, Bachilova S, Gopal D, Cabral HJ, Coddington CC, Stern JE. Embryo biopsy and maternal and neonatal outcomes following cryopreserved-thawed single embryo transfer. Am J Obstet Gynecol. 2021. doi:10.1016/j.ajog.2021.04.235.
  166. Makhijani R, Coulter M, Taggar A, Godiwala P, O’Sullivan D, Nulsen J, Engmann L, Benadiva C, Grow D. Reduction in multiple pregnancy rate in donor oocyte-recipient gestational carrier (GC) in vitro fertilization (IVF) cycles in the USA with single embryo transfer and preimplantation genetic testing. J Assist Reprod Genet. 2021. doi:10.1007/s10815-021-02112-5.
  167. Lee M, Kort J, Baker V. Embryo biopsy and perinatal outcomes of singleton pregnancies: An analysis of 16,246 frozen embryo transfer cycles reported in the Society for Assisted Reproductive Technology Clinical Outcomes Reporting System. Am J Obstet Gynecol. 2021. doi:10.1016/j.ajog.2020.10.043.
  168. Perlman B, Krishnamoorthy K, Morelli S, Greenberg P, Jindal S, McGovern PG. Increased male live birth rates after blastocyst-stage frozen-thawed embryo transfers compared with cleavage stage: a SART CORS study. FS Rep. 2021;2(2):161-5.
  169. Mejia RB, Capper EA, Summers KM, Ten Eyck P, Van Voorhis BJ. Elective transfer of one embryo is associated with a higher cumulative live birth rate and improved perinatal outcomes compared to transfer of two embryos with in vitro fertilization. FS Rep. 2021;2(1):50-7.
  170. Kotlyar AM, Simsek B, Seifer DB. Disparities in ART live birth and cumulative live birth outcomes for Hispanic and Asian women compared to non-white Hispanic women. J Clin Med. 2021;10(12):2615.
  171. Kawwass JF, Ten Eyck P, Sieber P, Hipp HS, Van Voorhis B. More than the oocyte source, egg donors as patients: a national picture of United States egg donors. J Assist Reprod Genet. 2021;38(5):1171-5.
  172. Tal R, Seifer DB, Tal R, Granger E, Tal O. AMH highly correlates with cumulative live birth rate in women with diminished ovarian reserve independent of age. J Clin Endocrinol Metab. 2021;106(9):2754-66.
  173. Kawwass JF, Crawford S, Hipp HS. Frozen eggs: national autologous oocyte thaw outcomes. Fertil Steril. 2021;116(4):1077-84.
  174. Katler QS, Shandley LM, Hipp HS, Kawwass JF. National egg-freezing trends: cycle and patient characteristics with a focus on race/ethnicity. Fertil Steril. 2021;116(2):528-37.
  175. Luke B, Brown MB, Wantman E, Forestieri N, Browne ML, Fisher SC, Yazdy MM, Ethen MK, Canfield MA, Nichols HB, Oehninger S, Doody KJ, Sutcliffe AG, Williams C, Eisenberg ML, Baker VL, Sacha CR, Lupo PJ. Risks of nonchromosomal birth defects, small-for-gestational-age birthweight, and prematurity with in vitro fertilization: effect of number of embryos transferred and plurality at conception versus at birth. J Assist Reprod Genet. 2021;38(4):835-46.
  176. Bhatt SJ, Marchetto NM, Roy J, Morelli SS, McGovern PG. Pregnancy outcomes following in vitro fertilization frozen embryo transfer (IVF-FET) with or without preimplantation genetic testing for aneuploidy (PGT-A) in women with recurrent pregnancy loss (RPL): a SART-CORS study. Hum Reprod. 2021;36(8):2339-44.
  177. Olcha M, Kuokkanen S, Xie X, Negassa A, Pal L, Jindal SK. The impact of Hurricane Katrina, a major natural disaster, on assisted reproductive technology outcomes through an analysis of 451,848 ART cycles. Sci Rep. 2021;11(1):17864.
  178. Libby V, DeVilbiss E, Chung M, Dilday E, Babayev SN, Weinerman R, Doody K. Obstetric outcomes in pregnancies resulting from in vitro fertilization are not different in fertile, sterilized women compared to infertile women: a Society for Assisted Reproductive Technology database analysis. Fertil Steril. 2021 Mar;115(3):617-26.\
  179. Luke B, Brown MB, Ethen MK, Canfield MA, Watkins S, Wantman E, Doody KJ. Sixth grade academic achievement among children conceived with IVF: a population-based study in Texas, USA. J Assist Reprod Genet. 2021;38(6):1481-92.
  180. Stern JE, Liu CL, Hwang S, Dukhovny D, Farland LV, Coddington CC, Cabral HG. Influence of placental abnormalities and pregnancy induced hypertension in prematurity associated with assisted reproductive technology techniques. J Clin Med. 2021;10:1681.
  181. Stern JE, Liu CL, Cui X, Gopal D, Cabral HJ, Coddington CC, Missmer SA, Hwang S, Farland LV, Dukhovny D, Diop H. Optimizing the control group for evaluating ART outcomes: can outpatient claims data yield a better control group? J Assist Reprod Genet. 2021;38(5):1089-1100.
  182. Dukhovny D, Hwang S, Gopal D, Cabral H, Diop H, Stern JE. Association of maternal fertility status and fertility treatment with healthcare utilization in infants up to age four. J Perinatol. 2021;41(10):2408-16.
  183. Farland LV, Stern JE, Hwang SS, Liu CL, Cabral H, Knowlton R, Gershman ST, Coddington CC, Missmer SA. Early-life cancer, infertility, and risk of adverse pregnancy outcomes: a registry linkage in Massachusetts. Cancer Causes Control. 2021;32(2):169-80.
  184. Hwang SS, Dukhovny D, Gopal D, Cabral H, Farland LV, Stern JE. Sex differences in infant health following ART-treated, subfertile, and fertile deliveries. J Assist Reprod Genet. 2021;38(1):211-8.
  185. Harris BS, Acharya KS, Weber JM, Truong T, Eaton JL. Can high antimullerian hormone mitigate some of the age-related decline in live birth rates? The association between antimullerian hormone and live birth among women over age 40 undergoing in vitro fertilization. FS Rep. 2021;2(4):440-7.
  186. Krishnamoorthy K, Greenberg P, Perlman BE, Morelli SS, Jindal SK, McGovern PG. The incidence of ectopic/heterotopic pregnancies after blastocyst-stage frozen-thawed embryo transfers compared with cleavage stage: a SART CORS study. FS Rep. 2021;2(4):421-7.
  187. Sarkar P, New EP, Jindal S, New EP, Sprague RG, Tanner JP, Imudia AN. The role of preimplantation genetic testing for aneuploidy in a good prognosis IVF population across different age groups. Syst Biol Reprod Med. 2021;67(5):366-73.
  188. Marsidi AM, Kipling LM, Kawwass JF, Mehta A. Influence of paternal age on assisted reproductive technology cycles and perinatal outcomes. Fertil Steril. 2021 Aug;116(2):380-7.
  189. Williams RS, Ellis DD, Wilkinson EA, Kramer JM, Datta S, Guzick D. Factors affecting live birth rates in donor oocytes from commercial egg banks vs. program egg donors: an analysis of 40,485 cycles from the Society for Assisted Reproductive Technology registry in 2016-2018. Fertil Steril. 2022;117(2):339-48.
  190. Awadwalla MS, Ho JR, McGinnis LK, Ahmady A, Cortessis VK, Paulson RJ. Embryo morphology and live birth in the United States. FS Rep. 2022;3(2):131-7.
  191. Acharya KS, Harris BS, Weber JM, Truong T, Pieper C, Eaton JL. Impact of increasing antimullerian hormone level on in vitro fertilization fresh transfer and live birth rate. FS Rep. 2022;3(3):223-30.
  192. Tsai S, Chung EH, Truong T, Ferrell AS, Wu J, Ohamadike O, Eaton JL. Racial and ethnic disparities among donor oocyte banks in the United States. Fertil Steril. 2022;117(3):622-8.
  193. Bedrick BS, Tipping AD, Nickel KB, Riley JK, Jain T, Jungheim ES. State-mandated insurance coverage and preimplantation genetic testing (PGT) in the United States. Obstet Gynecol. 2022;139(4):500-8.
  194. Gingold JA, Fazzari M, Gerber R, Kappy M, Goodman M, Lieman H, Pollack S, Singh M, Jindal S. Adherence to embryo transfer guidelines in favorable-prognosis patients aged less than 35 years using autologous oocytes and in recipients using donor oocytes: a Society for Assisted Reproductive Technology Clinic Outcome Reporting System study. Fertil Steril 2022 Mar;177(3):548-559.
  195. Mejia RB, Capper EA, Summers KM, Mancuso AC, Sparks AE, Van Voorhis BJ. Cumulative live birth rate in women aged <37 years after in vitro fertilization with or without preimplantation genetic testing for aneuploidy: a Society for Assisted Reproductive Technology Clinic Outcome Reporting System retrospective analysis.  FS Rep 2022; 3(3):184-91.
  196. Farland LV, Stern JE, Liu CL, Cabral HJ, Coddington CC, Diop H, Dukhovny D, Hwang S, Missmer SA.  Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study. Hum Reprod 2022; 37(11):2690-9.
  197. Luke B, Brown MB, Wantman E, Schymura MJ, Browne ML, Fisher SC, Forestieri NE, Rao C, Nichols HB, Yazdy MM, Gershman ST, Sacha CR, Williams M, Ethen MK, Canfield MA, Doody KJ, Eisenberg ML, Baker VL, Williams C, Sutcliffe AG, Richard MA, Lupo PJ. The risks of birth defects and childhood cancer with conception by assisted reproductive technology.  Hum Reprod 2022; 37(11):2672-89.
  198. Li M, Singh B, Baker VL. Association between embryo morphological quality and birth weight for singletons conceived via autologous fresh embryo transfer: an analysis using Society for Assisted Reproductive Technology Clinical Outcomes Reporting System. Li M, Singh B, Baker VL. Fertil Steril 2022; 118(4): 715-23.
  199. Farland LV, Stern JE, Hwang SS, Liu CL, Cabral H, Knowlton R, Gershman ST, Coddington CC, Missmer SA. History of cancer and fertility treatment outcomes: a registry linkage study in Massachusetts. J Assist Reprod Genet. 2022;39(2):517-26.
  200. Siegel DR, Grau L, Sammel M, Nel-Themaaat L, Santoro N, Polotsky AJ. Anti-mullerian hormone and follicle-stimulating hormone are poor independent predictors of live birth after assisted reproductive technology. Reprod Sci. 2022;30(4):1316-23.
  201. Bakkensen JB, Flannagan KSJ, Mumford SL, Hutchinson AP, Cheung EO, Moreno PL, Jordan N, Feinberg EC, Goldman KN. A SART data cost-effectiveness analysis of planned oocyte cryopreservation versus in vitro fertilization with preimplantation genetic testing for aneuploidy considering ideal family size. Fertil Steril. 2022;118(5):875-84.
  202. Carusi DA, Gopal D, Cabral HJ, Bormann CL, Racowsky C, Stern JE. A unique placenta previa risk factor profile for pregnancies conceived with assisted reproductive technology. Fertil Steril. 2022;118(5):894-903.
  203. George JS, Lee MS, Ashby RK, Goldman R, Ginsburg ES, Lanes A, Srouji SS. The impact of insurance mandates on donor oocyte utilization: an analysis of 39,338 donor oocyte cycles from the Society for Assisted Reproductive Technology registry. Am J Obstet Gynecol. 2022;227(6):877.e1-877.e11.
  204. Iwamoto A, Van Voorhis BJ, Summers KM, Sparks A, Mancuso AC. Intracytoplasmic sperm injection vs. conventional in vitro fertilization in patients with non-male factor infertility. Fertil Steril. 2022;118(3):465-72.
  205. Rauh-Hain JA, Zubizarreta J, Nitecki R, Melamed A, Fu S, Jorgensen K, Brady PC, Baker VL, Chavez-MacGregor M, Giordano SH, Keating NL. Survival outcomes following pregnancy or assisted reproductive technologies after breast cancer: a population-based study. Cancer. 2022;128(17):3243-53.
  206. Hynes JS, Weber JM, Truong T, Acharya KS, Eaton JL. Body mass index is negatively associated with a good perinatal outcome after in vitro fertilization among patients with polycystic ovary syndrome: A national study. F S Rep. 2022;4(1):77-84.
  207. Hurley EG, Sun F, Zhang H, Polotsky AJ, Rios JS. Minimal stimulation using gonadotropin-releasing hormone antagonist is associated with higher live birth rates: a national study of 13,050 cycles. Womens Health Rep. 2022;3(1):957-63.
  208. Correia KFB, Missmer SA, Weinerman R, Ginsburg ES, Rossi BV. Development of a model to estimate the optimal number of oocytes to attempt to fertilize during assisted reproductive technology treatment. JAMA Netw Open. 2023 Jan 3;6(1):e2250382.
  209. Jorgensen K, Meernik C, Wu CF, Murphy CC, Baker VL, Jarmon P, Brady PC, Nitecki R, Nichols HB, Rauh-Hain JA. Disparities in fertility-sparing treatment and use of assisted reproductive technology after a diagnosis of cervical, ovarian, or endometrial cancer. Obstet Gynecol. 2023 Feb 1;141(2):341-53.
  210. Arkfield C, Han E, Tal R, Seifer DB. AMH predicts miscarriage in non-PCOS but not in PCOS related infertility ART cycles. Reprod Biol Endocrinol. 2023;21(1):35. 
  211. Sadek S, Matitashvili T, Alddin RS, Morshedi B, Ramadan H, Dodani S, Bocca S. IVF outcomes following ICSI cycles using testicular sperm in obstructive (OA) vs. non-obstructive azoospermia (NOA) and the impact of maternal and paternal age: a SART CORS data registry. J Assist Reprod Genet. 2023;40(3):627-37.
  212. Carusi DA, Gopal D, Cabral HJ, Racowsky C, Stern JE. A risk factor profile for placenta accreta spectrum in pregnancies conceived with assisted reproductive technology. FS Reprod. 2023;4(3):279-85.
  213. Kucherov A, Fazzari M, Lieman H, Ball GD, Doody K, Jindal S. PGT-A is associated with reduced cumulative live birth rate in first reported IVF stimulation cycles age ≤40: an analysis of 133,494 autologous cycles reported to SART CORS. J Assist Reprod Genet. 2023;40(1):137-49.
  214. Meernik C, Jorgensen K, Wu CF, Murphy CC, Baker VL, Brady PC, Nitecki R, Nichols HB, Rauh-Hain JA. Disparities in the use of assisted reproductive technologies after breast cancer: a population-based study. Breast Cancer Res Treat. 2023 Feb;198(1):149-58.
  215. Li HJ, Seifer DB, Tal R. AMH independently predicts aneuploidy but not live birth per transfer in IVF PGT-A cycles. Reprod Biol Endocrinol. 2023 Feb 4;21(1):19.
  216. Seifer DB, Wang SF, Frankfurter D. Cumulative live birth rates with autologous oocytes plateau with fewer number of cycles for each year of age >42. Reprod Biol Endocrinol. 2023;21(1):94.
  217. Chu CS, Li D, Olson-Chen C, Kawwass J, Vitek W. Recurrence risk and risk factors for monozygotic twin and triplet birth in over 65,000 single-embryo transfers. J Assist Reprod Genet. 2023;40(4):851-55.
  218. Fanton M, Cho JH, Baker VL, Loewke K. A higher number of oocytes retrieved is associated with an increase in fertilized oocytes, blastocysts, and cumulative live birth rates. Fertil Steril. 2023 May;119(5):762-69.
  219. Meernik C, Engl SM, Wardell A, Baggett CD, Gupta P, Rodriguez-Ormaza N et al. Disparities in fertility preservation use among adolescent and young adult women with cancer. J Cancer Surviv. 2023 Oct;17(5):1435-44.
  220. Gingold JA, Wu H, Lieman H, Singh M, Jindal S. Comparing reproductive outcomes between conventional in vitro fertilization and nonindicated intracytoplasmic sperm injection in autologous embryo transfer cycles: A Society for Assisted Reproductive Technology Clinic Outcome Reporting System Study. F S Rep. 2023 Oct 29;5(1):23-32.
  221. Burks CA, Purdue-Smithe A, DeVilbiss E, Mumford S, Weinerman R. Frozen autologous and donor oocytes are associated with differences in clinical and neonatal outcomes compared with fresh oocytes: a Society for Assisted Reproductive Technology Clinic Outcome Reporting System Analysis. F S Rep. 2023 Nov 10;5(1):40-46.
  222. Shandley LM, DeSantis CE, Lee JC, Kawwass JF, Hipp HS. Trends and outcomes of assisted reproductive technology cycles using a gestational carrier between 2014 and 2020. JAMA. 2023 Nov 7;330(17):1691-94.
  223. Gerber RS, Kappy M, Gingold J, Wu H, Lieman HJ, Singh M, Pollack SE, Jindal S. Obstetric and neonatal outcomes after transferring more than one embryo in patients with preimplantation genetic testing. Obstet Gynecol. 2024 Jan 1;143(1):92-100.
  224. Van Heertum K, DeVilbiss EA, Goldfarb J, Mumford SL, Weinerman R. Does embryo biopsy, independent of vitrification, impact perinatal outcomes? An analysis of perinatal outcomes following preimplantation genetic testing biopsy in fresh and frozen embryo transfer cycles. F S Rep. 2024 Jan 28;5(1):47-54.
  225. Bakkensen JB, Strom D, Boots CE. Frozen embryo transfer outcomes decline with increasing female body mass index in female but not male factor infertility: analysis of 56,564 euploid blastocyst transfers. Fertil Steril. 2024 Feb;121(2):271-80.
  226. Peterson A, Wu H, Kappy M, Kucherov A, Singh M, Lieman H, Jindal S. Higher live birth rates are associated with a normal body mass index in preimplantation genetic testing for aneuploidy frozen embryo transfer cycles: a Society for Assisted Reproductive Technology Clinic Outcome Reporting System study. Fertil Steril. 2024 Feb;121(2):291-8.
  227. Kloos J, Burks C, Purdue-Smithe A, DeVilbiss E, Mumford SL, Weinerman R. Similar pregnancy outcomes from fresh and frozen donor oocytes transferred to gestational carriers: a SART database analysis isolating the effects of oocyte vitrification. J Assist Reprod Genet. 2024 Mar;41(3):643-8. doi:10.1007/s10815-023-03016-2. Epub 2024 Jan 11.
  228. Herweck A, DeSantis C, Shandley LM, Kawwass JF, Hipp HS. International gestational surrogacy in the United States, 2014-2020. Fertil Steril. 2024 Apr;121(4):622-30.
  229. Wang SF, Seifer DB. Age-related increase in live-birth rates of first frozen thaw embryo versus first fresh transfer in initial assisted reproductive technology cycles without PGT. Reprod Biol Endocrinol. 2024 Apr 13;22(1):42.
  230. Wang SF, Seifer DB. Assessment of a decade of change in U.S. assisted reproductive technology cumulative live-birth rates: 2004-2009 compared with 2014-2020. Obstet Gynecol. 2024 Jun 1;143(6):839-48.
  231. Kanbergs A, Jorgensen K, Agusti N, Viveros-Carreno D, Wu C, Nitecki R, Harris JA, Woodard T, Ramphul R, Rauh-Hain JA. Patient location and disparities in access to fertility preservation for women with gynecologic or breast cancer. Obstet Gynecol. 2024 Jun;143(6):824-34.
  232. Kahn JL, Wu H, Gerber R, Shah T, Lieman H, Pollack SE, Singh M, Jindal S. Protocol change improves live birth and recurrent cycle cancellation rates after a previous IVF cycle cancellation: an analysis of 13,000 autologous cycles reported to SART CORS. Hum Reprod. 2024 Jul;39(7):1504-11.
  233. Sarkar P, New EP, Jindal S, Tanner JP, Imudia AN. The effect of trophectoderm biopsy for preimplantation genetic testing on fetal birth weight and preterm delivery. Minerva Obstet Gynecol. 2024 Aug;76(4):327-34.
  234. Hobbs CL, Gadson AK, Sadikman S, Tsai S, Enemuo F, Raker C, Eaton JL. An investigation of racial and ethnic disparities in donor sperm availability in the United States. Fertil Steril. 2024 Sep;122(3):474-81.
  235. Traub AM, Shandley LM, Hipp HS, Kawwass JF. Gestational carrier cycles: embryology trends, national guideline compliance, and resultant perinatal outcomes in the United States, 2014-2020. Am J Obstet Gynecol. 2024 Oct;231(4):446.
  236. Kawwass JFAH, Shah T, Wu H, Lieman HJ, Singh M, Pollack SE, Jindal S. Trophectoderm biopsy is associated with lower risks of moderate to extreme prematurity and low birthweights: a national registry cohort study of singleton livebirths from frozen-thawed blastocyst transfers. Am J Obstet Gynecol. 2024 Dec;231(6):636.e1-636.e9.
  237. Brioso X, Kuokkanen S, Akerman M, Pal L. Racial disparities in the outcomes of euploid single frozen-thawed embryo transfer cycles - analysis of the Clinical Outcome Reporting System of the Society for Assisted Reproductive Technology 2016-2018 data. Fertil Steril. 2024 Dec;122(6):1026-36.
  238. Gingold JA, Kucherov A, Wu H, Fazzari M, Lieman H, Ball GD, Doody K, Jindal S. Preimplantation genetic testing for aneuploidy is associated with reduced live birth rates in fresh but not frozen donor oocyte in vitro fertilization cycles: an analysis of 18,562 donor cycles reported to Society for Assisted Reproductive Technology Clinic Outcome Reporting System. Fertil Steril. 2025 Jan;123(1):50-60.
  239. Yilmaz BD, Bakkensen J, Yeh C, Muhammad LN, Feinberg EC. Development of a novel calculator to predict gonadotropin dose and oocyte yield in oocyte cryopreservation cycles. J Assist Reprod Genet. 2025 Feb;42(2):423-32.
  240. Harris BS, Acharya KS, Unnithan S, Neal SA, Mebane S, Truong T, Muasher SJ. Success rates with preimplantation genetic testing for aneuploidy (PGT-A) in good prognosis patients is dependent on age. Fertil Steril. 2025 Mar;123(3):428-38.
  241. Claffey A, Ngo A, McIntire D, Doody K, Doody K. Unveiling clinic variation in utilization of ICSI, PGT, and blastocyst transfer: a comprehensive study using the SART database (2014-2020). J Assist Reprod Genet. 2025 Mar;42(3):799-807.
  242. Ellington TD, Wardell AC, Deal AM, Mersereau J, Cameron K, Spandorfer S, Murugappan G, Baker VL, Anders C, Mitra S, Anderson C, Cai J, Luke B, Nichols HB. In vitro fertilization with cryopreserved oocytes or embryos after cancer: the role of gestational carriers. Cancer. 2025 Apr 14;131(8).
  243. Tsai S, Ma X, Spring S, Spandorfer S. More isn’t always better: analysis of surplus cryopreserved blastocysts in fresh donor oocytes cycles. JAMA Netw Open. 2025 Apr 21;8(4). Epub ahead of print.
  244. Mason-Otey A, Seifer DB. United States racial/ethnic disparities in PGT-A utilization: an analysis of 2014-2020 SART CORS database. Reprod Biol Endocrinol. 2025 May 10;23(1):66.
  245. Anderson C, Wardell AC, Deal AM, Mersereau JE, Cameron K, Spandorfer SD, Baker VL, Mitra S, Cai J, Luke B, Nichols HB. Fertility preservation and in vitro fertilization (IVF) success rate after cancer. JNCI Cancer Spectr. 2025 Jun 1;9(4).
  246. Chen AL, Shufeng L, Baker VL, Lupo PJ, Nichols HB, Eisenberg M, Luke B. The prevalence of parental cancer history and in vitro fertilization utilization. J Natl Cancer Inst. 2025 Jul 1;117(7):1485-91.
  247. Schmiech K, Li M, Chen LX, Dow MP, Baker VL. Association of endometrial thickness with live birth rate: a study using the Society for Assisted Reproductive Technology Clinic Outcome Reporting System. Fertil Steril. 2025 Jul;124(1):79-87.
  248. Chemerinski A, Blackledge K, Greenberg P, Douglas NC, McGovern PG, Morelli SS. Age does not affect maximal endometrial thickness achieved in frozen embryo transfer cycles: a SARTCORS study. Reprod Biol Endocrinol. 2025 Aug 2;23(1):115.
  249. Wang SF, Seifer DB. Comparative Age-Stratified Analysis of Live Birth Outcomes in Primary Embryo Transfer: to Assess the Effect of Preimplantation Genetic Testing for Aneuploidy. Obstet Gynecol 2025 Aug 21 (Online ahead of print)
  250. Tsai S, Ma X, Spring S, Spandorfer S. Optimizing the Number of Frozen Donor Oocytes to Fertilize While Minimizing Supernumerary Embryos. Human Repro 2025 Sept (online ahead of print)

Submitted/In preparation:

  1. Park H, Sundaram R, Bell EM, Bell G, Ghassabian A, Lawrence DA, Luke B, Yeung E. Newborn biomarkers on infectious and respiratory diseases during early childhood. In preparation.
  2. Luke B, Brown MB, Wantman E, Meyer RE, Foresteri N, Watkins S, Yazdy M, Browne M, Fisher S, Canfield MA, Ethen M, Nichols HB, Oehninger S, Doody K. Risk of blastogenesis birth defects in IVF, non-IVF ART, and fertile births. In preparation.
  3. Bocca S, Mahesan A, Luke B, Brown MB, Wantman E, Oehninger S. Risk of congenital malformations in ICSI with surgically obtained sperm: A US study in four States. In preparation.
  4. Walsh TJ, Raheem O, Chen T, Alukal J, Nangia A, Luke B. Impact of male factors on pregnancy outcomes with assisted reproductive technologies. In preparation.
  5. Peyser A, Goldman R, Blitz MJ, Vohra N, Bristow S, Leung TM, Lesser M, Hershlag A.  Monozygosity in ART in the United States: Society for Assisted Reproductive Technology (SART) data from 2005-2015.  Submitted for publication.
FAQs

FAQs

Have questions about IVF and infertility? We have answers.
Find A Clinic

Find A Clinic

National statistics from SART member clinics that reported their data through SART.